Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

  • Oscar Dumoulin

    Oscar Dumoulin is a Global Market Access Consultant at Alira Health where he has extensively collaborated with big pharmaceutical companies to optimize their pricing and market access strategy. Oscar previously worked at Boehringer Ingelheim and holds a MSc in Public Health from the London School of Hygiene and Tropical Medicine and a BSc. in Biology from McGill University, Montreal, Canada.

  • Aaron Grandy

    Aaron Grandy is a Global Market Access Engagement Manager at Alira Health where he has led projects involving a broad range of Market Access topics and regularly supports multiple global and local market access teams in communicating and understanding the value of their products. Prior to moving into consulting, Aaron held a Global Market Access position at Novartis in Basel, Switzerland. Aaron is also an aspiring entrepreneur and has a start-up in Nigeria called GoMed, which aims to alleviate access barriers for medicines for African patients by digitally empowering local community pharmacies. Aaron holds a PhD in Molecular Biology (Oncology) awarded from the German Cancer Research Centre (DKFZ) and the University of Heidelberg, Germany, and an MBA from the EAE Business School, Barcelona, Spain.

  • Ahmad Bechara

    Ahmad Bechara is Managing Partner, Global Market Access at Alira Health. Prior to joining Alira Health, Ahmad was a Director at Wellmera AG with over 18 years of experience in both the pharmaceutical industry and academic research. Ahmad has developed multiple access and launch strategies for global and local teams and submitted dossiers to the World Health Organization. Ahmad holds a PhD in Genetics and Neuroscience from the University of Claude Bernard in Lyon.


You May Also Like

How Pharma Can Contribute to the Quantified Self Movement

The Quantified Self (QS) movement, or lifelogging as some people call it, just keeps ...

Why Social Listening Has Become Essential To Pharma

For years, pharma stood by and watched as social media grew from a mere ...

Trendsetter: Ed Fotsch, MD, of PDR Network

Edward Fotsch, MD, is chief executive officer of PDR Network, a provider of drug ...